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Abstract
To investigate the burden of influenza-like illness (ILI), patients
attending an emergency department during the influenza season
were tested for several common respiratory viruses, using PCR-
based methods. Influenza A viruses were detected in 25 of 103
recruited patients (24%), rhinoviruses in 15%, and respiratory
syncytial virus in only one. The data suggest that triage criteria
based on ILI case definitions would not contain the spread of
the influenza virus during pandemic alerts and could lead to
unnecessary isolation of patients with other infections. Applica-
tion of broader triage criteria followed by timely molecular diag-
nosis could be effective in preventing new respiratory agent
transmission.
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A clinical diagnosis is considered to be predictive of influenza
during the seasonal epidemic period [1]; however, hospital-
ized patients do not usually present with classic influenza
syndrome, but with pulmonary complications of influenza
and symptoms such as dyspnoea, thoracic pain, syncope or
deterioration of existing conditions [2,3]. Lack of laboratory-
confirmed data on influenza burden in emergency depart-
ments (EDs) could hamper efforts to evaluate the relative
impact of a new pandemic virus and to reduce the risk of
transmission [4,5].
In the framework of a respiratory infection surveillance
project, a study was undertaken during February/March 2009
of consecutive patients attending the ED of ‘Umberto I’ hos-
pital (‘Sapienza’ University, Rome). The study period started
2 weeks after the seasonal influenza peak [6], the time at
which most serious influenza-related complications in adults
occur [7]. Inclusion criteria were as follows: presenting with
fever at admission or during the preceding 5 days, plus one
of the following diagnoses (ICD-9 codes)—pharyngitis, acute
(462); bronchitis, acute (466.0); bronchopneumonia (485);
pneumonia (480–486); dyspnoea and respiratory distress
(786.0); cough (786.2); thoracic pain (786.5); abnormal find-
ings on diagnostic images of lung (793.1); influenza (487);
influenza with pneumonia (487.0); influenza with other respi-
ratory manifestations (487.1). Informed consent and clinical
data were obtained from 103 enrolled patients who, after
medical examination, were admitted to hospital, kept under
medical observation for 6–48 h, or sent to their general
practitioner.
Nasopharyngeal washes (NPWs) were collected, and RNA
extraction was undertaken within 1–5 h. Reverse transcrip-
tions with random examers and PCRs specific for influenza
viruses A and B, respiratory syncytial virus (RSV) and rhino-
viruses were undertaken as previously described [8].
Influenza A-positive PCR results were found in 24% of
NPWs, all positive samples being collected in February (25/
55: 45%); influenza B virus was not detected. A subset of 31
NPWs with a rapid influenza test (Now Flu A/B; Inverness)
had only one positive result for influenza A, whereas ten of
31 samples tested positive for influenza A with the PCR test.
A possible explanation for the rapid test sensitivity being
even lower than previously reported [9,10] is that, in our
patients, infection began days before ED attendance, and only
sensitive molecular tests could detect it. Although a positive
PCR reaction does not necessarily indicate the presence of
viable viruses, the potential for influenza transmission should
be considered. Influenza virus loads were recently reported
as remaining persistently high in hospitalized patients with
comorbidities [11].
Patients infected with the influenza A virus presented
more frequently with cough and dyspnoea, but did not pres-
ent with typical influenza systemic symptoms (headache,
asthenia, arthralgia, myalgia, and chest pain) any more
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frequently than other patients (Table 1). No significant differ-
ences were found between influenza A-infected patients and
rhinovirus-positive or virus-negative patients in terms of
either pre-existing health conditions or subsequent hospital-
ization.
Rhinoviruses were detected in 17 of 103 samples, one of
which was also positive for influenza A virus (Table 1); sub-
stantial rates of rhinovirus infection have previously been
reported in hospitalized adults, in whom the clinical presen-
tation may resemble influenza [12]. We found only one RSV-
positive sample; however, there may be a higher prevalence
of RSV infection in hospitalized adults earlier in winter [13].
In our series of tests, the influenza-like illness (ILI) case
definition [6] would be only 20% efficient (sensitivity) in rec-
ognizing influenza virus-positive patients, whereas 31 patients
negative for influenza virus would be identified as ILI cases.
Triage criteria of presenting with fever or preceding fever
and cough or dyspnoea had a low positive predictive value
(31%; 95% CI 20–42), but the high negative predictive value
(86%; 95% CI 74–98) would be useful in excluding influenza.
These results raise concerns about the numbers of influ-
enza virus-positive patients who would not be recognized
using ILI case definitions such as those used by the European
CDC [14]. Wide, relatively unrestrictive criteria for triage,
such as the European CDC acute respiratory infection case
definition (sudden onset of symptoms, one respiratory symp-
tom (cough, sore throat, shortness of breath, or coryza) plus
a clinician’s judgement that the illness is due to an infection),
would result in an elevated negative predictive value for the
influenza virus, but the low positive predictive value would
lead to isolation of patients either not infectious or affected
by other respiratory pathogens.
Triage criteria during a pandemic alert should be different
from those used during normal epidemic seasons, because
identification of infected patients is fundamental to achieving
effective control of outbreaks [15,16]. As the symptoms of
pandemic influenza A 2009 H1N1 infection resemble those
of seasonal influenza [17], application of broader triage crite-
ria would enable containment of the highest number of
infected patients. Such a strategy should include timely
molecular diagnoses of at least common pathogens, because
the fact that procedures confirming the presence of the pan-
demic influenza are undertaken at reference centres might
lead to reductions in restrictions on or treatment of patients
infected with other viruses.
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RSV, n = 1
Negative,
n = 61c
Age >65 years 16 (64.0) 15 (88.2)d 34 (55.7)d
Vaccinatede 15 (60.0) 13 (76.5) 36 (59.0)
Fever 14 (56.0) 12 (70.5) 44 (72.1)
Preceding fever 11 (44.0) 5 (29.4) 17 (27.8)
Cough 20 (80.0)f 8 (47.0) 29 (47.5)f
Influenza symptomsg 6 (24.0) 6 (35.3) 25 (40.9)
Dyspnoea 20 (80.0)h 6 (35.3) 13 (21.3)h
Thoracic pain 4 (16.0) 2 (11.8) 15 (24.6)
ILI casesi 5 (20.0) 6 (35.3) 25 (40.9)
ILI, influenza-like illness; RSV, respiratory syncytial virus.
aPercentage of patient samples in each group.
bOne sample positive for influenza A virus and rhinovirus was included with
influenza A patient samples.
cSamples negative for influenza A and B viruses, RSV, and rhinovirus.
dPatients aged >65 years in the rhinovirus/RSV group vs. negative: p <0.05, cal-
culated using chi-squared test.
ePatients who received seasonal influenza vaccine.
fPatients with cough in the influenza A virus group vs. negative: p <0.05, calcu-
lated using chi-squared test.
gTypical influenza symptoms: headache, asthenia, arthralgia, myalgia, and chest
pain.
hPatients with dyspnoea in the influenza A virus group vs. negative: p <0.01, cal-
culated using chi-squared test.
iILI case definition provided by the Italian Ministry of Health [6], i.e. fever (tem-
perature ‡ 38C), with at least one of headache, asthenia, or myalgia, and
at least one of the following respiratory symptoms: cough, rhinitis, or acute
pharyngitis.
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